Title MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma
Authors Li, Yifan
Guan, Bao
Liu, Jingtao
Zhang, Zhongyuan
He, Shiming
Zhan, Yonghao
Su, Boxing
Han, Haibo
Zhang, Xiaochun
Wang, Boqing
Li, Xuesong
Zhou, Liqun
Zhao, Wei
Affiliation Peking Univ, Natl Urol Canc Ctr, Hosp 1, Dept Urol,Inst Urol, Beijing 100034, Peoples R China
Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Pharm Dept, Beijing 100142, Peoples R China
Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Cell Biol, Beijing 100142, Peoples R China
Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Hepatopancreatobiliary Surg, Urumqi 830011, Xinjiang, Peoples R China
Keywords Renal cell carcinoma
MicroRNA-200b
LAMA4
Metastasis
Issue Date 2019
Publisher EBIOMEDICINE
Abstract Background: Metastasis is the primary cause of tumor death in renal cell carcinoma (RCC). Improved diagnostic markers of metastasis are critically needed for RCC. MicoRNAs are demonstrated to be stable and significant biomarkers for several malignancies. In this study, we aimed to explore the metastasis related microRNAs and its mechanism in KC. Methods: The relationship between microRNAs expression and prognosis and metastasis of RCC patients were explored by data mining through expression profiles from The Cancer Genome Atlas (TCGA). A total of 80 RCC tissues and adjacent normal kidney tissues were obtained from Department of Urology, Peking University First Hospital. Expression of microRNA-200b (miR-200b) in RCC tissues and cell lines were determined by bioinformatic data mining and quantitative real-time PCR (qRT-PCR). The effects of miR-200b on cell proliferation, migration and invasion were determined by cell counting kit-8 and colony formation assay, wound healing assay and Boyden chamber assay. Mouse cell-derived xenograft and patient-derived xenograft model were also performed to evaluate the effects of miR-200b on tumor growth and metastasis in vivo. The molecular mechanism of miR-200b function was investigated using bioinformatic target predication and high-throughput cDNA sequencing (RNA-seq) and validated by luciferase reporter assay, qRT-PCR, Western blot and immunostaining in vitro and in vivo. Findings: Our findings indicates that miR-200b is frequently downregulated and have potential utility as a biomarker of metastasis and prognosis in RCC. Interestingly, ectopic expression of miR-200b in the Caki-1 and OSRC-2 cell lines suppresses cell migration and invasion in vitro as well as tumor metastases in vivo. However, miR-200b has no effect on cell proliferation in vitro and tumor growth in vivo. In addition, bioinformatics target predication and RNA-seq results reveals that Laminin subunit alpha 4 (LAM4) is one target of miR-200b and significantly inhibited by miR-200b in vitro and in vivo. Interpretation: These results demonstrate a previously undescribed role of miR-200b as a suppressor of tumor metastasis in RCC by directly destabilizing LAMA4 mRNA. (C) 2019 Published by Elsevier B.V.
URI http://hdl.handle.net/20.500.11897/547740
ISSN 2352-3964
DOI 10.1016/j.ebiom.2019.05.041
Indexed SCI(E)
Appears in Collections: 第一医院
北京肿瘤医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.